Evaluation of the GORE PV1 Device in Patients With Pulmonary Valve Dysfunction
Active, not recruiting · Not applicable · NCT03441971
Conditions: Heart Defects, Congenital, Tetralogy of Fallot, Pulmonary Valve Insufficiency, Pulmonary Valve Stenosis
At a glance
- Research payments reported, 2025
- $16,830
- U.S. investigators named
- 0
- Sites paid
- 2
- Planned or actual enrollment
- 15
About the trial
- Sponsor
- W.L.Gore & Associates
- Tested
- GORE PV1 (device)
- Dates
- Started 2018-06-07; completion 2030-03
- Results posted
- Not yet
This study will assess the safety and performance of the GORE PV1 Device for replacement of the pulmonary valve and reconstruction of the Right Ventricular Outflow Tract (RVOT).
From ClinicalTrials.gov, last updated 2026-02-05. Full record, eligibility and contacts (opens in a new tab)
Industry funding
W. L. Gore & Associates, Inc. reported $16,830 in research payments for this study in 2025 (2 payments).
Products named: Product in Development
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
Sites paid to run it
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.